Cite
HARVARD Citation
Vandenberghe, R. et al. (2017). Active Aβ immunotherapy CAD106 in Alzheimer's disease: A phase 2b study. Alzheimer's & dementia. 3 (1), pp. 10-22. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Vandenberghe, R. et al. (2017). Active Aβ immunotherapy CAD106 in Alzheimer's disease: A phase 2b study. Alzheimer's & dementia. 3 (1), pp. 10-22. [Online].